Cardiovascular Health News

PHILADELPHIA — In this video exclusive, Cynthia A. Stuenkel, MD, MSCP, talks about selecting therapies for menopausal symptoms for women with a history of cardiovascular disease.

Researchers reported that two novel risk classification scores correctly classified patients with valvular heart disease living in India who developed adverse CV outcomes during pregnancy and childbirth.

Use of any substance during pregnancy, including alcohol and cannabis but especially methamphetamines, is associated with increased risk for acute CV outcomes during delivery hospitalization, according to a nationwide database analysis.

Menstrual cycle irregularity and age at menarche were significantly associated with parameters of cardiometabolic health in early adulthood among a mostly Black cohort of young women, researchers reported.

Pregnancy brings risks for serious or even fatal complications for people of reproductive age with HF, and obstetricians and cardiologists should work together to ensure those risks are minimized, according to a new review.

DANA POINT, Calif. — Clinicians must use a tailored approach when treating women with HF, who have risk factors, biomarkers and manifestations of disease that are often distinctly different from men, according to a speaker.

DANA POINT, Calif. — In this Healio video exclusive, Fatima Cody Stanford, MD, MPA, MPH, MBA, discusses considerations clinicians must make regarding women with obesity.

DANA POINT, Calif. — Peripheral artery disease remains underdiagnosed and undertreated among women worldwide and efforts are needed to increase awareness, improve diagnoses and ensure patient referrals, according to a speaker.

DANA POINT, Calif. — Cardiometabolic health promotion should start early, be creative and include interventions that “focus on health, not just disease” to optimize outcomes for underserved populations, according to a speaker.

DANA POINT, Calif. — In this Healio video exclusive, Keith C. Ferdinand, MD, discusses resistant hypertension, which he said “is the most powerful and potent cardiovascular risk factor in women.”